Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-51,500
Closed -$2.02M 4229
2019
Q4
$2.02M Sell
51,500
-20,000
-28% -$735K ﹤0.01% 2461
2019
Q3
$2.56M Buy
71,500
+20,900
+41% +$750K ﹤0.01% 2171
2019
Q2
$1.77M Buy
+50,600
New +$1.76M ﹤0.01% 2317
2017
Q2
Sell
-13,300
Closed -$546K 3527
2017
Q1
$546K Buy
+13,300
New +$555K ﹤0.01% 2689

Other funds holding SNV

D.E. Shaw & Co's SNV Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Synovus (SNV) in Q1 2026, closing a stake of 675,464 shares — an estimated $33.8M sold.

D.E. Shaw & Co first reported a position in SNV in Q2 2013 and held it in 42 quarters. The position peaked at $47.8M in Q3 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • D.E. Shaw & Co reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 675,464 Synovus shares in Q1 2026, an estimated $33.8M.
  • D.E. Shaw & Co first reported a position in Synovus in Q2 2013 and held it in 42 quarters.
  • D.E. Shaw & Co's Synovus position peaked at $47.8M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.